Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

DuPont Merck prepares anticoagulant aminoboronic acids

July 21, 1997

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

July 17, 1997

Potent, orally active fibrinogen antagonist developed at Merck & Co.

July 17, 1997

Texas Biotechnology initiates NDA filing for Novastan

July 16, 1997

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

July 16, 1997

Lp(a)-dependent actions of LMWH

July 14, 1997

Antithrombotic efficacy of TAK-029 in animal models

July 11, 1997

Roberts seeks European approval of Agrylin

July 11, 1997

ReoPro effective in baboon models of human renal disorders

July 11, 1997

Factor Xa inhibitors from Berlex

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...